Listen to audio brief:

The White House has issued a new order aimed at lowering prescription drug prices for Americans, highlighting the importance of reviving efforts from previous years. This initiative includes proposals for enhanced transparency in drug pricing, modifications to Medicare programs, and strategies to address anti-competitive practices among pharmaceutical companies. Through these changes, the administration seeks to ensure that Americans have access to affordable medications while also encouraging innovation within the pharmaceutical sector.

Original: article